Therapeutic effect of jizusoippo for symptoms of Yusho patients exposed to dioxins

Therapeutic effect of jizusoippo for symptoms of Yusho patients exposed to dioxins - Effect of jizusoippo for Yusho

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000010377

Enrollment

Registered

2013-04-15

Start date

2013-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Yusho disease

Interventions

Patients take 2.5g of Jizusoippo three times a day after each meal for 6months.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients aged 20 years or older who fulfilled the diagnostic criteria for Yusho established by the National Study Group for the Therapy of Yusho and give their written informed consents are eligible.

Exclusion criteria

Exclusion criteria: Patients are not eligible if they have serious diseases (malignant neoplasms, hepatic disorders, renal disorders, or blood disorders), have been treated with any other Kampo formulae, or are women with pregnancy or nursing women. Patients who are judged to have an ineligible health condition by medical doctors are excluded.

Design outcomes

Primary

Measure	Time frame
respiratory, skin, and neurological symptoms, general fatigue, and QOL	—

Countries

Japan

Contacts

Public ContactHiroshi Uchi

Kyushu University Hospital Research and Clinical Center for Yusho

092-642-5211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026